Ulodesine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameUlodesine
Drug Alias Nameulodesinum优洛地新DADMe-Immucillin-HulodesinaUlodesine succinate +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsHyperuricemiaPsoriasisRenal Insufficiency +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals IncF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHyperuricemiaPsoriasisRenal Insufficiency +[6] 

Other Information

ATC CodeN/A
Related LinksKEGG